Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
出版年份 2010 全文链接
标题
Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
作者
关键词
-
出版物
PLoS One
Volume 5, Issue 6, Pages e11406
出版商
Public Library of Science (PLoS)
发表日期
2010-07-01
DOI
10.1371/journal.pone.0011406
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Attenuated poxvirus vectors MVA and NYVAC as promising vaccine cadidates against HIV/AIDS
- (2014) Mariano Esteban Human vaccines & immunotherapeutics
- A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian Volunteers
- (2009) Vadakkuppatu Devasenapathi Ramanathan et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Vaccinia virus vaccines: Past, present and future
- (2009) Bertram L. Jacobs et al. ANTIVIRAL RESEARCH
- Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2
- (2009) S. Backes et al. JOURNAL OF GENERAL VIROLOGY
- Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
- (2009) P. Mooij et al. JOURNAL OF VIROLOGY
- Vaccinia Virus K1L and C7L Inhibit Antiviral Activities Induced by Type I Interferons
- (2009) X. Meng et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
- (2009) Xiaoxing Huang et al. PLoS One
- The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer
- (2008) Carmen Gomez et al. CURRENT GENE THERAPY
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara
- (2008) Eric Sandström et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy
- (2008) Florencia Pereyra et al. JOURNAL OF INFECTIOUS DISEASES
- Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates
- (2008) P. Mooij et al. JOURNAL OF VIROLOGY
- CD8+ T cell efficacy in vaccination and disease
- (2008) Victor Appay et al. NATURE MEDICINE
- Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic
- (2008) M. Corbett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toward an AIDS Vaccine
- (2008) B. D. Walker et al. SCIENCE
- Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes
- (2008) Kaifan Dai et al. VACCINE
- Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine
- (2008) Audrey Ferrier-Rembert et al. VACCINE
- Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Intra-nasal vaccination
- (2007) Sangeetha Vijaysri et al. VACCINE
- Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines
- (2007) Linda S. Wyatt et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now